On Apr. 16, 2020, Scripps Research announced that researchers at Calibr, Scripp’s drug development division, had established an international network of collaborating scientific laboratories to leverage ReFRAME, the worldﾒs leading drug repurposing collection, to find antiviral compounds against the novel coronavirus.

Calibr established the ReFRAME collection in 2018 with support from the Bill & Melinda Gates Foundation to tackle areas of urgent unmet medical need, especially neglected tropical diseases. The collection has since grown to comprise over 14,000 compounds, including drugs that are already being repurposed for a number of diseases.